Adjuvant Sunitinib in Renal-Cell Carcinoma

被引：4
|
作者：
Zhang, Sheng [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 376卷 / 09期
关键词：
RISK;
D O I：
10.1056/NEJMc1616636
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：893 / 893
页数：1
相关论文
共 50 条
  • [21] Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
    Motzer, Robert J.
    Hutson, Thomas E.
    Tomczak, Piotr
    Michaelson, M. Dror
    Bukowski, Ronald M.
    Rixe, Olivier
    Oudard, Stephane
    Negrier, Sylvie
    Szczylik, Cezary
    Kim, Sindy T.
    Chen, Isan
    Bycott, Paul W.
    Baum, Charles M.
    Figlin, Robert A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02): : 115 - 124
  • [22] Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
    Choueiri, T. K.
    Tomczak, P.
    Park, S. H.
    Venugopal, B.
    Ferguson, T.
    Chang, Y. -H.
    Hajek, J.
    Symeonides, S. N.
    Lee, J. L.
    Sarwar, N.
    Thiery-Vuillemin, A.
    Gross-Goupil, M.
    Mahave, M.
    Haas, N. B.
    Sawrycki, P.
    Gurney, H.
    Chevreau, C.
    Melichar, B.
    Kopyltsov, E.
    Alva, A.
    Burke, J. M.
    Doshi, G.
    Topart, D.
    Oudard, S.
    Hammers, H.
    Kitamura, H.
    Bedke, J.
    Perini, R. F.
    Zhang, P.
    Imai, K.
    Willemann-Rogerio, J.
    Quinn, D. I.
    Powles, T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (08): : 683 - 694
  • [23] ROLE OF ADJUVANT RADIOTHERAPY IN MANAGEMENT OF RENAL-CELL CARCINOMA
    RAFLA, S
    PARIKH, KJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1980, 6 (10): : 1418 - 1418
  • [24] Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
    Choueiri, T. K.
    Tomczak, P.
    Park, S. H.
    Venugopal, B.
    Ferguson, T.
    Symeonides, S. N.
    Hajek, J.
    Chang, Y-H
    Lee, J-L
    Sarwar, N.
    Haas, N. B.
    Gurney, H.
    Sawrycki, P.
    Mahave, M.
    Gross-Goupil, M.
    Zhang, T.
    Burke, J. M.
    Doshi, G.
    Melichar, B.
    Kopyltsov, E.
    Alva, A.
    Oudard, S.
    Topart, D.
    Hammers, H.
    Kitamura, H.
    McDermott, D. F.
    Silva, A.
    Winquist, E.
    Cornell, J.
    Elfiky, A.
    Burgents, J. E.
    Perini, R. F.
    Powles, T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (15): : 1359 - 1371
  • [25] Adjuvant therapy for renal-cell carcinoma: settled for now
    Duensing, Stefan
    Hohenfellner, Markus
    LANCET, 2016, 387 (10032): : 1973 - 1974
  • [26] Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
    Sharma, Aparna
    Sahoo, Ranjit K.
    Batra, Atul
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (20): : 1919 - 1919
  • [27] Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
    Motzer, Robert J.
    Penkov, Konstantin
    Haanen, John
    Rini, Brian
    Albiges, Laurence
    Campbell, Matthew T.
    Venugopal, Balaji
    Kollmannsberger, Christian
    Negrier, Sylvie
    Uemura, Motohide
    Lee, Jae L.
    Vasiliev, Aleksandr
    Miller, Wilson H., Jr.
    Gurney, Howard
    Schmidinger, Manuela
    Larkin, James
    Atkins, Michael B.
    Bedke, Jens
    Alekseev, Boris
    Wang, Jing
    Mariani, Mariangela
    Robbins, Paul B.
    Chudnovsky, Aleksander
    Fowst, Camilla
    Hariharan, Subramanian
    Huang, Bo
    di Pietro, Alessandra
    Choueiri, Toni K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (12): : 1103 - 1115
  • [28] Adjuvant Sunitinib for Renal Cell Carcinoma: Still at the Beginning of the Road
    Carretero-Gonzalez, Alberto
    de Velasco, Guillermo
    KIDNEY CANCER, 2018, 2 (01) : 1 - 3
  • [29] Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma
    Staehler, Michael
    Battle, Dena
    Bex, Axel
    Hammers, Hans
    George, Daniel
    EUROPEAN UROLOGY, 2018, 74 (06) : 842 - 843
  • [30] Adjuvant sunitinib in renal cell carcinoma: from evidence to recommendation
    Bex, A.
    ANNALS OF ONCOLOGY, 2017, 28 (04) : 682 - 684
12345